Machine Learning

Dr. Amanda Wilson's appointment to a powerful D.C. council puts her tech-driven addiction treatment model in the national policy spotlight.

With two pivotal trial readouts looming and cash projected to last only into Q4, Tvardi Therapeutics faces a make-or-break year for its STAT3 inhibitors.

Travel tech giant Amadeus navigates geopolitical turbulence with solid Q1 growth, while a major acquisition signals a bold future for frictionless travel.

How one company turned its internal training program into a strategic powerhouse, earning a top award and creating a blueprint for the future of work.

At a top Paris expo, GUYU's biotech arm BioQ unveiled cellular anti-aging ingredients, signaling a new era of Chinese innovation in the beauty supply chain.

An innovative RNA-editing therapy for hepatocellular carcinoma has received a major FDA designation, potentially accelerating its path to patients.

A new fund, NICO, challenges ESG norms by investing in tobacco giants, aiming to force a shift to safer products. Can engagement succeed where exclusion has failed?

SimScale has launched Engineering AI agents that automate entire simulation workflows, promising to eliminate bottlenecks and slash design cycles from months to hours.

A three-month FDA delay for a new LEQEMBI injection highlights the high-stakes race for a convenient Alzheimer's therapy and its complex safety hurdles.

A KIST-led delegation of Korean quantum startups partners with IBM, signaling a major push to commercialize deep tech on the global stage.

A Swedish startup is launching a 'participation-first' video app in Brazil, betting that users are tired of passive scrolling. Can it succeed?

Faraday Future and a new business school are launching an ambitious robotics institute, but can they deliver on the promise to standardize the future of AI?

A new, free AI platform, MattsonIQ™, promises to democratize expert food intelligence, but what does it mean for the future of R&D and market competition?

The chipmaker topped Q1 estimates and eyes a strong Q2, fueled by EV and AI markets, even as restructuring charges weigh on its bottom line.

With a strong balance sheet and promising data, Enliven Therapeutics is pushing its lead leukemia drug, ELVN-001, into a pivotal late-stage trial.

Semiconductor giant KLA announces a massive stock split and a 21% dividend hike, rewarding shareholders and making its stock more accessible to all.

Artivion posts strong Q1 results and acquires Endospan for its FDA-approved NEXUS system, yet lowers its full-year guidance. What's behind the mixed message?

New data shows most college students are 'Blank Slates' to AI hiring systems. Are universities and traditional career prep failing an entire generation?

Sen. Tim Scott, Cathie Wood, and Thomas Lee headline a landmark crypto conference, signaling digital assets' pivotal shift from fringe to mainstream finance.

A new AI-powered technology can spot deadly high potassium levels using a simple smartwatch ECG, a breakthrough that could transform remote patient care.